Aclarion, Inc. (ACON)
ACON Stock Price Chart
Explore Aclarion, Inc. interactive price chart. Choose custom timeframes to analyze ACON price movements and trends.
ACON Company Profile
Discover essential business fundamentals and corporate details for Aclarion, Inc. (ACON) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Healthcare Information Services
IPO Date
22 Apr 2022
Employees
5.00
Website
https://www.aclarion.comCEO
Brent Ness
Description
Aclarion, Inc., a healthcare technology enterprise based in San Mateo, California, was founded in 2008 and operates within the United States. The company specializes in creating software for magnetic resonance spectroscopy (MRS) applications. Its primary product is the NOCISCAN-LS Post-Processor suite, which features two key components: NOCICALC-LS, designed to analyze MRS data from discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a software tool that assists in clinical decision-making. The company adopted its current name, Aclarion, Inc., in December 2021, having previously been known as Nocimed, Inc.
ACON Financial Timeline
Browse a chronological timeline of Aclarion, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Aug 2026
EPS estimate is -$1.05, while revenue estimate is $30.00k.
Earnings released on 21 May 2026
EPS came in at -$1.34 surpassing the estimated -$1.55 by +13.55%, while revenue for the quarter reached $20.00k , meeting expectations.
Earnings released on 25 Feb 2026
EPS came in at -$3.60 matching the estimated -$3.60, while revenue for the quarter reached $20.00k , meeting expectations.
Earnings released on 12 Nov 2025
EPS came in at -$2.93 falling short of the estimated -$2.64 by -10.98%, while revenue for the quarter reached $18.94k , missing expectations by -0.31%.
Earnings released on 14 Aug 2025
EPS came in at -$2.75 falling short of the estimated -$2.26 by -21.68%, while revenue for the quarter reached $19.32k , missing expectations by -35.60%.
Earnings released on 15 May 2025
EPS came in at -$9.32 surpassing the estimated -$1.45k by +99.36%, while revenue for the quarter reached $18.99k , missing expectations by -5.05%.
Stock split effective on 28 Mar 2025
Shares were split 1 : 27 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 27 Mar 2025
EPS came in at -$1.55k falling short of the estimated -$50.00 by -3.00k%, while revenue for the quarter reached $10.23k .
Stock split effective on 30 Jan 2025
Shares were split 1 : 335 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Nov 2024
EPS came in at -$1.35k surpassing the estimated -$1.62k by +16.67%, while revenue for the quarter reached $14.41k , missing expectations by -3.95%.
Earnings released on 14 Aug 2024
EPS came in at -$1.35k falling short of the estimated -$0.19 by -711.14k%, while revenue for the quarter reached $10.97k , beating expectations by +4.49%.
Earnings released on 15 May 2024
EPS came in at -$3.96k falling short of the estimated -$0.57 by -695.33k%, while revenue for the quarter reached $10.11k , beating expectations by +1.14%.
Earnings released on 2 Apr 2024
EPS came in at -$13.87k falling short of the estimated -$1.60 by -866.47k%, while revenue for the quarter reached $13.80k , missing expectations by -90.80%.
Stock split effective on 4 Jan 2024
Shares were split 1 : 16 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Nov 2023
EPS came in at -$17.30k falling short of the estimated -$13.02k by -32.80%, while revenue for the quarter reached $19.07k , missing expectations by -74.58%.
Earnings released on 25 Aug 2023
EPS came in at -$25.95k falling short of the estimated -$0.09 by -28.83m%, while revenue for the quarter reached $17.07k , missing expectations by -65.86%.
Earnings released on 3 Jul 2023
EPS came in at -$0.15 falling short of the estimated -$0.10 by -50.00%, while revenue for the quarter reached $25.47k , beating expectations by +1.88%.
Earnings released on 27 Feb 2023
EPS came in at -$24.46k falling short of the estimated -$911.20 by -2.58k%, while revenue for the quarter reached $22.52k , missing expectations by -2.09%.
Earnings released on 14 Nov 2022
EPS came in at -$0.21 falling short of the estimated -$0.12 by -75.00%, while revenue for the quarter reached $18.22k , beating expectations by +1.23%.
Earnings released on 15 Aug 2022
EPS came in at -$0.49 falling short of the estimated -$0.11 by -345.45%, while revenue for the quarter reached $10.68k , missing expectations by -2.95%.
Earnings released on 6 Jun 2022
EPS came in at -$1.03 , while revenue for the quarter reached $9.03k .
Earnings released on 31 Dec 2021
EPS came in at -$63.21k , while revenue for the quarter reached $11.98k .
Earnings released on 30 Sept 2021
EPS came in at -$6.58 , while revenue for the quarter reached $10.87k .
ACON Stock Performance
Access detailed ACON performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
